Trial reportBMJ open2026
TIPS (Trans-Tasman Internet-delivered Prevention of (youth) Suicide) study: protocol for a randomised controlled trial of mobile health interventions (four apps) to help young people reduce suicidal ideation.
Trial report in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSuicidal ideation is common in young people and increases the risk of suicide. Effective interventions that are relevant and accessible to young people, so-called digital natives, are urgently required. There are key questions regarding the cross-cultural efficacy of suicide prevention applications (apps) for scalability. METHODS AND ANALYSIS: This online four-arm parallel randomised controlled superiority trial will enrol 1480 young people aged 16-24 years with current suicidal ideation in New Zealand and Australia. Participants will be randomised to one of three therapeutic apps developed in different countries, Tune In, Bro and LifeBuoy, or to My Mood (attention control). The primary outcome is suicidal ideation severity at 30-day and 90-day post-baseline; secondary outcomes include mental well-being, engagement and acceptability. Emotional regulation will be examined as a mediator of change in suicidal ideation. All outcomes are measured by self-reported scales incorporated in an online questionnaire. Acceptability of the apps for rangatahi Māori (Indigenous youth, New Zealand) will be explored via semi-structured interviews. Linear mixed models with repeated measures analyses, using maximum likelihood estimation, an appropriate covariance structure and consideration of site effects, will be undertaken. Examination of an individual app intervention effects in New Zealand and Australia will highlight the effects of apps developed for a different country. ETHICS AND DISSEMINATION: Approval was obtained (26 February 2025) from the Health and Disability Ethics Committees (Ministry of Health ref 2025 EXP 21500). Participants provide informed consent online. Trial results will be submitted for publication in peer-reviewed journals, shared on relevant websites and via presentation at international scientific conferences; Individial Patient Data will only be shared if requested and subsequent to review. TRIAL REGISTRATION NUMBER: ACTRN12625000349448.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.